Literature DB >> 2667354

Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs.

M L Stiles1, Y H Tu, L V Allen.   

Abstract

The stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in prefilled drug reservoirs that were stored at -20 degrees C for 30 days, thawed at 5 degrees C for four days, and pumped at 37 degrees C for one day was studied. Each antimicrobial agent was diluted with sterile water for injection to a concentration representative of the most common dosage when administered via a portable infusion pump. Ten milliliters of each drug solution was placed in individual glass vials to serve as controls, and volumes appropriate to deliver the designated dosages were loaded into the drug reservoirs. Triplicate reservoirs were prepared for each drug. One-milliliter samples from all containers were taken on days 0, 30, 31, 32, 33, 34, 34.5, and 35. All solutions were observed for color change and precipitation. Drug concentrations were determined using high-performance liquid chromatography. Leaching of the plasticizer diethylhexyl phthalate (DEHP) was analyzed by packed-column gas chromatography on days 0 and 35. No color change or precipitation was observed. No DEHP concentrations above 1 ppm were detected. More than 90% of the initial concentrations of each drug remained, except penicillin G sodium, which had a mean concentration of 83.9 +/- 0.5% at the end of the study. Cefazolin sodium, cefoxitin sodium, and ceftazidime in admixtures with sterile water for injection are stable under the conditions of this study. Penicillin G sodium should not be administered for more than 12 hours after such a cycle of freezing and thawing.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2667354

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  7 in total

Review 1.  Systematic review of stability data pertaining to selected antibiotics used for extended infusions in outpatient parenteral antimicrobial therapy (OPAT) at standard room temperature and in warmer climates.

Authors:  Stephen John Perks; Cassie Lanskey; Niechole Robinson; Tilley Pain; Richard Franklin
Journal:  Eur J Hosp Pharm       Date:  2019-06-20

2.  Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.

Authors:  H Servais; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 3.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis.

Authors:  Andrew Burke; Daniel Smith; Chris Coulter; Scott C Bell; Rachel Thomson; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2021-05-13       Impact factor: 5.577

4.  Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.

Authors:  Devyani Deshpande; Shashikant Srivastava; Paula Bendet; Katherine R Martin; Kayle N Cirrincione; Pooi S Lee; Jotam G Pasipanodya; Keertan Dheda; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

5.  Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint Infection.

Authors:  Zoé Cavalli; Agathe Becker; Alexie Bosch; Anne Conrad; Claire Triffault-Filit; Florent Valour; Frederic Laurent; Sabine Cohen; Christian Chidiac; Tristan Ferry
Journal:  J Bone Jt Infect       Date:  2018-09-07

6.  Stability Studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy.

Authors:  Guillaume Loeuille; Elise D'Huart; Jean Vigneron; Yann-Eric Nisse; Benoit Beiler; Caroline Polo; Gillian Ayari; Matthieu Sacrez; Béatrice Demoré; Alexandre Charmillon
Journal:  Antibiotics (Basel)       Date:  2022-03-29

7.  Stability and Compatibility Aspects of Drugs: The Case of Selected Cephalosporins.

Authors:  Szymon Tomczak; Aleksandra Gostyńska; Malwina Nadolna; Karolina Reisner; Marta Orlando; Anna Jelińska; Maciej Stawny
Journal:  Antibiotics (Basel)       Date:  2021-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.